Patent · US Active

Template-directed nucleic acid targeting compounds

US11859242B2 · kind B2 · utility

0Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2018
Grant dateJan 2, 2024
Priority date
Expiry dateNov 21, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/51
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Described herein are genetic recognition reagents comprising terminal aromatic moieties that bind specifically to a template nucleic acid and concatenate. Also provided are methods of using the genetic recognition reagents, e.g., to treat or diagnose a repeat expansion disorder, such as DMI.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.